Dyslipidemia
460
26
36
320
Key Insights
Highlights
Success Rate
93% trial completion (above average)
Published Results
80 trials with published results (17%)
Research Maturity
320 completed trials (70% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
5.0%
23 terminated out of 460 trials
93.3%
+6.8% vs benchmark
28%
128 trials in Phase 3/4
25%
80 of 320 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 320 completed trials
Clinical Trials (460)
Vitamin D Status and Lipid Profile in Obese Adults With Type 2 Diabetes
Effect of macaúba Oil Combined With Green Exercises
Effects of Policosanol and Exercise on Fitness and Lipids in People With Elevated Blood Lipids
Kodo Millet Porridge and Its Effects on Gut Health and Metabolic Syndrome
Cardiometabolic Effects of the Recommended Daily Pecan Intake Dose
A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4954 in Healthy Adult Participants With or Without Elevated Lipoprotein (a) (Lp[a]) Levels, and Participants With Dyslipidemia
To Evaluate the Safety and Pharmacokinetic Characteristics of AJU-C716 and C716R in Healthy Adults
Taiwan Green Propolis for Blood Lipids and Body Fat in Patients With MASLD
Study to Evaluate the Safety and the Pharmacokinetics of "UI111" and "UIC202006" Under Fed Conditions
Electronic Health Record Augmented LDL-Cholesterol Optimization and Control Via Active Lipid Engagement (EHR-LOCALE): A Quality Improvement Implementation Study
A Randomized, Open-label, Two-arm, Two-period, Multiple-dose, Study to Evaluate Pharmacokinetic Drug-drug Interaction, Safety and Tolerability of UIC202601 and UIC202602 in Healthy Volunteers
Polypills Approach for Multiple Cardiovascular Risk Factors
Reducing Inflammation to Improve Vascular and Bone Outcomes With Low-dose Colchicine in CKD
Moderate-Intensity Statin Plus Ezetimibe in CKD and ASCVD
To Test the Effectiveness and Implementation Approach of a 3-month PILI Pasifika Program Lifestyle Program With Components of Social Determinants of Health Activities in Real-world Settings (Clinical and Non-clinical Settings) Across 3 Years
Polyunsaturated Fatty Acids-based Bars Effect on Metabolic Syndrome Patients
Lipoprotein Metabolism in Normal Volunteers and Patients With High Levels of Lipoproteins
EFFECTS OF A YERBA MATE EXTRACT IN REDUCING METABOLIC SYNDROME IN OVERWEIGHT INDIVIDUALS
Exercise Impact in Elderly With Multimorbidity: HbA1c and Blood Pressure
A Study to Evaluate the Safety and Pharmacokinetics of AD-231 Compared to Coadministration of AD-231A, AD-231D and AD-231C